First Trust NYSE Arca Biotechnology Index Fund
188 hedge funds and large institutions have $744M invested in First Trust NYSE Arca Biotechnology Index Fund in 2019 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 83 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
188
Holders Change
-34
Holders Change %
-15.32%
% of All Funds
4.13%
Holding in Top 10
2
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-66.67%
% of All Funds
0.04%
New
19
Increased
50
Reduced
83
Closed
51
Calls
$1.56M
Puts
$687K
Net Calls
+$873K
Net Calls Change
-$238K
Top Buyers
| 1 |
Millennium Management
New York
|
+$23M |
| 2 |
JPMorgan Chase & Co
New York
|
+$5.23M |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$3.03M |
| 4 |
AIC
Ameritas Investment Company
Lincoln,
Nebraska
|
+$2.65M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.39M |
Top Sellers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$578M |
| 2 |
Morgan Stanley
New York
|
-$74.4M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$56.6M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$25.9M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$24.4M |
